2009
DOI: 10.4088/jcp.08m04628yel
|View full text |Cite
|
Sign up to set email alerts
|

Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics

Abstract: Our study developed accurate ANN and logistic regression models to detect MetS in patients with SGA treatment. The models are likely to provide a noninvasive tool for large-scale screening of MetS in this group of patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
32
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(34 citation statements)
references
References 44 publications
1
32
1
Order By: Relevance
“…This is a non-parametric pattern recognition method that can recognize hidden patterns between independent and dependent variables [13]. Although ANN has been used in oncology, diabetes, hypertension, and other diseases [14][21], none have developed and evaluated the feasibility of the ANN model for predicting the risk of dyslipidemia in rural adults. Thus, it is unclear whether the ANN model is reliable and effective to identify those at high risk of dyslipidemia.…”
Section: Introductionmentioning
confidence: 99%
“…This is a non-parametric pattern recognition method that can recognize hidden patterns between independent and dependent variables [13]. Although ANN has been used in oncology, diabetes, hypertension, and other diseases [14][21], none have developed and evaluated the feasibility of the ANN model for predicting the risk of dyslipidemia in rural adults. Thus, it is unclear whether the ANN model is reliable and effective to identify those at high risk of dyslipidemia.…”
Section: Introductionmentioning
confidence: 99%
“…The results of the current study are consistent with the findings of other studies that evaluated the efficiency of ANN on the prediction of other diseases, including hypertension (26), diabetes (27), and coronary artery disease (28), predicting metabolic syndrome (29), complications of diabetes (30), gastric cancer (31), and other cancerous lesions (25,32), and predicting mortality in patients with sepsis (33); in all the mentioned studies, ANN had a higher efficacy than logistic regression in predicting the studied outcomes.…”
Section: Discussionsupporting
confidence: 81%
“…Theoretically this three-subtype model might serve as a framework to examine the different psychopathologic processes regarding the heterogeneity of schizophrenia. In the future we will use an artificial neural network to offer convenient clinical applications, 50 and use prospective studies on FE schizophrenia with stringent follow-up, as well as psychopharmacologic, neurobiologic, and genetic studies to retest this three-subtype model.…”
Section: Discussionmentioning
confidence: 99%